Ngan-Ming Tsang

Title: Ngan-Ming Tsang: Innovator in Cancer Radiotherapy

Introduction

Ngan-Ming Tsang is a notable inventor based in Tao-Yuan, Taiwan. He has made significant contributions to the field of cancer treatment, particularly in enhancing the effectiveness of radiotherapy for patients suffering from nanopharyngeal cancer. His innovative approach focuses on the role of leukemia inhibitory factor in cancer diagnosis and treatment.

Latest Patents

Ngan-Ming Tsang holds a patent titled "Potentiation of nanopharyngeal cancer radiotherapy by inhibitors of leukemia inhibitory factor." This patent outlines a method for evaluating cancer diagnosis following radiotherapy. The method involves providing a serum sample from a cancer patient prior to treatment and measuring the concentration of leukemia inhibitory factor in that sample. Additionally, the patent describes a method for enhancing cancer radiotherapy by administering a leukemia inhibitory factor inhibitor or receptor inhibitor to patients in need.

Career Highlights

Ngan-Ming Tsang is affiliated with Chang Gung University, where he continues to advance research in cancer therapies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.

Collaborations

Ngan-Ming Tsang collaborates with esteemed colleagues, including Yu-Sun Chang and Shu-Chen Liu, who contribute to his research efforts in the field of cancer radiotherapy.

Conclusion

Ngan-Ming Tsang's innovative work in cancer radiotherapy exemplifies the impact of research and invention in improving medical treatments. His contributions are paving the way for more effective cancer therapies and better patient care.